TRAF7 and familial pancreatic carcinoma: Our data demonstrate that MT1G promotes the degradation of NF-κB p65 subunit via tumor necrosis factor receptor-associated factor 7 (TRAF7), thus limiting activin A secretion and suppressing pancreatic cancer cell stemness.